Simon Harford
Finanzdirektor/CFO bei AMICUS THERAPEUTICS, INC.
Profil
Simon John Harford is currently a Non-Executive Director at C4X Discovery Holdings Plc and the Chief Financial Officer at Amicus Therapeutics, Inc. He previously served as a Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd., Group Vice President & Controller at Avon Products, Inc., Vice President & Controller at Eli Lilly & Co., Chief Financial Officer & Senior Vice President at PAREXEL International Corp., Senior VP-Finance & Global Pharmaceuticals at GSK Plc, and Chief Financial Officer & Treasurer at Albireo Pharma, Inc. Mr. Harford holds an MBA from the University of Virginia Darden School of Business.
Aktive Positionen von Simon Harford
| Unternehmen | Position | Beginn |
|---|---|---|
| C4X DISCOVERY HOLDINGS PLC | Direktor/Vorstandsmitglied | 20.04.2021 |
| AMICUS THERAPEUTICS, INC. | Finanzdirektor/CFO | 21.08.2023 |
Ehemalige bekannte Positionen von Simon Harford
| Unternehmen | Position | Ende |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Finanzdirektor/CFO | 20.08.2018 |
| GSK PLC | Corporate Officer/Principal | 01.04.2017 |
| ALBIREO PHARMA, INC. | Finanzdirektor/CFO | - |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Direktor/Vorstandsmitglied | - |
| AVON PRODUCTS, INC. | Comptroller/Controller/Auditor | - |
Ausbildung von Simon Harford
| University of Virginia Darden School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| GLAXOSMITHKLINE PHARMACEUTICALS LIMITED | Health Technology |
| GSK PLC | Health Technology |
| C4X DISCOVERY HOLDINGS PLC | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Avon Products, Inc.
 Avon Products, Inc. Household/Personal CareConsumer Non-Durables Avon Products, Inc. engages in the manufacture and marketing of cosmetics and beauty related products. It operates through the following geographical segments: Europe, Middle East and Africa; South Latin America, North Latin America, and Asia Pacific. It offers beauty products such as skincare, fragrance, and color cosmetics; fashion and home items, which consists of fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children's products, and nutritional products. The company was founded by David H. McConnell in 1886 and is headquartered in Northampton, the United Kingdom. | Consumer Non-Durables |
PAREXEL International Corp.
 PAREXEL International Corp. Miscellaneous Commercial ServicesCommercial Services PAREXEL International Corp. provides biopharmaceutical services. It offers clinical research and logistics, medical communications, consulting, commercialization and advanced technology products and services for pharmaceutical, biotechnology and medical device industries. The company was founded in 1983 and is headquartered in Newton, MA. | Commercial Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
